Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Tefibazumab> ?p ?o }
Showing triples 1 to 53 of
53
with 100 triples per page.
- Tefibazumab abstract "Tefibazumab (named Aurexis but not approved) is a humanized monoclonal antibody for the treatment of severe infections with Staphylococcus aureus. Possible indications include the treatment of S. aureus in a phase 2a patients with cystic fibrosis and of methicillin-resistant S. aureus.It was developed by Inhibitex.".
- Tefibazumab atcPrefix "none".
- Tefibazumab casNumber "521079-87-8".
- Tefibazumab wikiPageID "9686038".
- Tefibazumab wikiPageRevisionID "592871557".
- Tefibazumab atcPrefix "none".
- Tefibazumab c "6548".
- Tefibazumab casNumber "521079".
- Tefibazumab chemspiderid "NA".
- Tefibazumab h "10122".
- Tefibazumab hasPhotoCollection Tefibazumab.
- Tefibazumab kegg "D06054".
- Tefibazumab mabType "mab".
- Tefibazumab molecularWeight "147.59".
- Tefibazumab n "1730".
- Tefibazumab o "2034".
- Tefibazumab s "44".
- Tefibazumab source "zu/o".
- Tefibazumab target Clumping_factor_A.
- Tefibazumab tradename "Aurexis".
- Tefibazumab type "mab".
- Tefibazumab verifiedfields "changed".
- Tefibazumab verifiedrevid "470478505".
- Tefibazumab subject Category:Monoclonal_antibodies.
- Tefibazumab type Abstraction100002137.
- Tefibazumab type Antibody115027189.
- Tefibazumab type Chemical114806838.
- Tefibazumab type Compound114818238.
- Tefibazumab type Macromolecule114944888.
- Tefibazumab type Material114580897.
- Tefibazumab type Matter100020827.
- Tefibazumab type Molecule114682133.
- Tefibazumab type MonoclonalAntibodies.
- Tefibazumab type MonoclonalAntibody115029781.
- Tefibazumab type OrganicCompound114727670.
- Tefibazumab type Part113809207.
- Tefibazumab type PhysicalEntity100001930.
- Tefibazumab type Protein114728724.
- Tefibazumab type Relation100031921.
- Tefibazumab type Substance100019613.
- Tefibazumab type Thing100002452.
- Tefibazumab type Unit109465459.
- Tefibazumab type Drug.
- Tefibazumab type DrugProduct.
- Tefibazumab type FunctionalSubstance.
- Tefibazumab comment "Tefibazumab (named Aurexis but not approved) is a humanized monoclonal antibody for the treatment of severe infections with Staphylococcus aureus. Possible indications include the treatment of S. aureus in a phase 2a patients with cystic fibrosis and of methicillin-resistant S. aureus.It was developed by Inhibitex.".
- Tefibazumab label "Tefibazumab".
- Tefibazumab sameAs m.02pp33k.
- Tefibazumab sameAs Q7694629.
- Tefibazumab sameAs Q7694629.
- Tefibazumab sameAs Tefibazumab.
- Tefibazumab wasDerivedFrom Tefibazumab?oldid=592871557.
- Tefibazumab isPrimaryTopicOf Tefibazumab.